middle.news
Invion Reveals FDA Orphan Drug Nod Behind Surge in Shares
8:29pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Invion Reveals FDA Orphan Drug Nod Behind Surge in Shares
8:29pm on Friday 29th of August, 2025 AEST
Key Points
FDA grants Orphan Drug Designation for INV043 targeting anal cancer
Invion unaware of FDA decision before public disclosure
Significant share price rise and trading volume spike on ASX
Company confirms compliance with ASX continuous disclosure rules
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE